{
  "schema_version": 1,
  "nct_id": "NCT07835828",
  "title": "Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease",
  "status": "RECRUITING",
  "conditions": [
    "Chronic Kidney Disease",
    "Heart Failure With Preserved Ejection Fraction (HFPEF)",
    "Cardiovascular Diseases"
  ],
  "source": {
    "name": "ClinicalTrials.gov",
    "nct_id": "NCT07835828",
    "url": "https://clinicaltrials.gov/study/NCT07835828",
    "retrieved": "2026-11-16",
    "modified": "Eligibility criteria structured and coded (SNOMED CT, LOINC, RxNorm) by ChartStays from the ClinicalTrials.gov text; the original text is kept unchanged in eligibility.criteria_text. Criteria curated by the project team, not reviewed by clinicians; pre-screening only.",
    "last_update_posted": "2026-10-15"
  },
  "eligibility": {
    "criteria_text": "Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Capable of giving written informed consent\n* Established chronic kidney disease, and at least two measurements of: 1) eGFR \\<45 and \\>15 mL/min/1.73 m², and/or 2) UACR \\>200 mg/g, or 3) eGFR \\<60 mL/min/1.73 m² and UACR \\>30 mg/g.\n* Established cardiovascular disease, including prior acute coronary syndrome, chronic coronary syndrome, objective evidence of myocardial ischaemia, non-coronary atherosclerotic cardiovascular diase (stroke or peripheral arterial disease), heart failure with preserved ejection fraction, atrial fibrillation and/or flutter, clinically significant valvular disease, or hypertension treated with three or more antihypertensive drugs.\n\nExclusion Criteria:\n\n* Established heart failure with reduced ejection fraction.\n* Diabetes type I or II\n* Patients receiving chronic dialysis or having of kidney transplant.\n* Expected life expectancy \\<5 years.\n* Inability to understand the study procedures, comply with study requirements, or presence of any condition that, in the opinion of the research staff, may interfere with the patient's ability to participate in or complete the study.\n* Participation in another clinical trial with an investigational product or device that could interfere with the primary and/or secondary endpoints of this study.",
    "sex": "ALL",
    "minimum_age": "18 Years",
    "maximum_age": null,
    "healthy_volunteers": false
  },
  "structured": [
    {
      "id": "inc-0a",
      "type": "inclusion",
      "kind": "age",
      "label": "Age 18 years or older",
      "source_text": "ClinicalTrials.gov age limits: 18 Years minimum, none maximum",
      "min": 18,
      "max": null,
      "unit": "years"
    },
    {
      "kind": "condition",
      "label": "Established cardiovascular disease, including prior events",
      "codes": {
        "snomed": [
          "414545008",
          "22298006",
          "401314000",
          "401303003",
          "88805009",
          "60573004",
          "48724000"
        ]
      },
      "note": "Coded: ischemic heart disease, myocardial infarction, chronic heart failure and valvular disease found in the Synthea sample. Stroke, peripheral arterial disease, atrial fibrillation and treated hypertension rely on the free text. Chronic heart failure (88805009) does not record the ejection fraction: heart failure with reduced ejection fraction is excluded by exc-1 (free text), so a match here still needs that check.",
      "id": "inc-4a",
      "type": "inclusion",
      "source_text": "Established cardiovascular disease, including prior acute coronary syndrome, chronic coronary syndrome, objective evidence of myocardial ischaemia, non-coronary atherosclerotic cardiovascular diase (stroke or peripheral arterial disease), heart failure with preserved ejection fraction, atrial fibrillation and/or flutter, clinically significant valvular disease, or hypertension treated with three or more antihypertensive drugs."
    },
    {
      "kind": "condition",
      "label": "Type 2 diabetes",
      "codes": {
        "snomed": [
          "44054006"
        ]
      },
      "note": "Type 1 diabetes is not coded in the Synthea sample and relies on the free text.",
      "id": "exc-2a",
      "type": "exclusion",
      "source_text": "Diabetes type I or II"
    }
  ],
  "free_text": [
    {
      "id": "inc-2",
      "type": "inclusion",
      "text": "Capable of giving written informed consent"
    },
    {
      "id": "inc-3",
      "type": "inclusion",
      "text": "Established chronic kidney disease, and at least two measurements of: 1) eGFR <45 and >15 mL/min/1.73 m², and/or 2) UACR >200 mg/g, or 3) eGFR <60 mL/min/1.73 m² and UACR >30 mg/g."
    },
    {
      "id": "inc-4",
      "type": "inclusion",
      "text": "Established cardiovascular disease, including prior acute coronary syndrome, chronic coronary syndrome, objective evidence of myocardial ischaemia, non-coronary atherosclerotic cardiovascular diase (stroke or peripheral arterial disease), heart failure with preserved ejection fraction, atrial fibrillation and/or flutter, clinically significant valvular disease, or hypertension treated with three or more antihypertensive drugs."
    },
    {
      "id": "exc-1",
      "type": "exclusion",
      "text": "Established heart failure with reduced ejection fraction."
    },
    {
      "id": "exc-2",
      "type": "exclusion",
      "text": "Diabetes type I or II"
    },
    {
      "id": "exc-3",
      "type": "exclusion",
      "text": "Patients receiving chronic dialysis or having of kidney transplant."
    },
    {
      "id": "exc-4",
      "type": "exclusion",
      "text": "Expected life expectancy <5 years."
    },
    {
      "id": "exc-5",
      "type": "exclusion",
      "text": "Inability to understand the study procedures, comply with study requirements, or presence of any condition that, in the opinion of the research staff, may interfere with the patient's ability to participate in or complete the study."
    },
    {
      "id": "exc-6",
      "type": "exclusion",
      "text": "Participation in another clinical trial with an investigational product or device that could interfere with the primary and/or secondary endpoints of this study."
    }
  ],
  "requested_fields_for_inquiry": [
    "age",
    "conditions"
  ],
  "curation": {
    "method": "manual"
  }
}
